TAK-683

 

Topic mentions per year

Topic mentions per year

2012-2018
012320122018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
TAK-448 and TAK-683 are kisspeptin agonist analogs with improved in vivo stability and activity. Previous studies showed that… (More)
Is this relevant?
2017
2017
This study aimed to examine the response of luteinizing hormone (LH) secretion and ovarian steroid profile to TAK-683, an… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2015
2015
This study aimed to evaluate the hormonal and ovarian responses to the administration of a metastin/kisspeptin analog (TAK-683… (More)
Is this relevant?
2014
2014
This study evaluated the effects of follicular phase administration of TAK-683, an investigational metastin/kisspeptin analog, on… (More)
Is this relevant?
2014
2014
The continuous activation of the kisspeptin receptor by its agonists causes the abrogation of kisspeptin signaling, leading to… (More)
Is this relevant?
2014
2014
Kisspeptin/metastin, a hypothalamic peptide, plays a pivotal role in controlling gonadotropin-releasing hormone (GnRH) neurons… (More)
Is this relevant?
2013
2013
AIMS Two randomized, double-blind, placebo-controlled studies were performed to characterize the safety, tolerability… (More)
Is this relevant?
2013
2013
The aim of the present study was to determine if the estradiol-induced luteinizing hormone (LH) surge is influenced by the… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
Metastin/kisspeptin is a 54 amino acid peptide ligand of the KISS1R receptor and is a critical regulator of GnRH secretion. The N… (More)
Is this relevant?
2012
2012
TAK-448 and TAK-683, investigational agents with potential utility in the treatment of prostate cancer, are potent low molecular… (More)
Is this relevant?